An epidermal growth factor receptor variant III-targeted...

Molecular Cancer Therapeutics 2009 / 10 Vol. 8; Iss. 10

An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme

Sampson, J. H., Archer, G. E., Mitchell, D. A., Heimberger, A. B., Herndon, J. E., Lally-Goss, D., McGehee-Norman, S., Paolino, A., Reardon, D. A., Friedman, A. H., Friedman, H. S., Bigner, D. D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
8
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-09-0124
Date:
October, 2009
File:
PDF, 152 KB
english, 2009
Conversion to is in progress
Conversion to is failed